Table 1 Patient cohort characteristics
From: Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patients
Patients | 180 |
|---|---|
Median age | 66 (34-87) |
Sex | |
Male | 108 (60%) |
Female | 72 (40%) |
Histology | |
Adenocarcinoma | 129 (72%) |
Squamous cell carcinoma | 43 (24%) |
Not otherwise specified | 6 (3%) |
Pleomorphic carcinoma | 2 (1%) |
Stage of disease | |
IIIA | 4 (2%) |
IIIB | 19 (11%) |
IIIC | 4 (2%) |
IVA | 75 (42%) |
IVB | 78 (43%) |
Tumor tissue NGS | |
NGS analysis performed | 132 (73%) |
NGS analysis not performed | 48 (27%) |
Rearrangement analysis of tumor tissue | |
IHC or FISH analysis performed | 63 (35%) |
NanoString analysis performed | 58 (32%) |
Archer analysis performed | 4 (2%) |
Rearrangement analysis not performed | 55 (31%) |
